In the third quarter of 2026, Bitcoin mining in the US, Russia, and China made up about 65.4% of the global hashrate. The US led with 35.6% but saw a decline from the previous quarter, while Russia's share increased to 18.1%. China's share decreased slightly to 11.7%. The total global hashrate remained nearly unchanged at around 941 exahashes per second. These shifts indicate changing dynamics in Bitcoin mining power distribution among the top countries, though the overall network strength stayed stable.
Bitcoin mining hashrate distribution in Q3 2026 is the subject, with the US, Russia, and China holding 65.4% of global power. For readers following cryptocurrency markets, here is Pluang's snapshot as of Oct 07, 2026 02:32 WIB: out of 50 major cryptocurrencies, 14 rose and 35 fell today. Notable price changes include SXP down 46.27% at Rp37, BAL up 11.14% at Rp16.297, and EOS up 8.13% at Rp12.649.
Neogen reported earnings per share of $0.08 and revenue of $222.8 million, both exceeding analyst expectations. The company also announced a strategic partnership with Hinalea Imaging Corp. to develop digital food safety tools. However, Neogen's stoc...
PepsiCo is set to report its Q3 2026 earnings with expectations of $2.29 EPS and $25 billion revenue. The company faces challenges in North America, where organic revenue declined due to pricing pressures and changing consumer preferences. To adapt, ...
Stryker experienced an 8.8% stock drop on September 8, 2026, wiping out over $10 billion in market value due to ongoing manufacturing problems that were thought resolved. Truist Financial lowered its price target from $340 to $310, reflecting concern...
Bank OZK is scheduled to release its Q3 2026 earnings after market close on October 20, providing investors with updated financial results to compare against Citigroup's current Sell rating. The bank's latest balance sheet shows $41.70 billion in tot...
Scotiabank has increased its price target for Pfizer stock from $30.00 to $33.00, suggesting a potential upside of 20.9% from the current trading price of $27.31. Pfizer, a major pharmaceutical company, holds a strong buy rating with a Zacks Rank of ...
